Talis Ebitda from 2010 to 2024
TLIS Stock | USD 8.95 0.23 2.64% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -60.7 M | Current Value -63.7 M | Quarterly Volatility 48.5 M |
Check Talis Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Talis main balance sheet or income statement drivers, such as Net Interest Income of 50.4 K, Interest Income of 50.4 K or Depreciation And Amortization of 3.2 M, as well as many exotic indicators such as Price To Sales Ratio of 34.51, Dividend Yield of 0.0 or PTB Ratio of 0.21. Talis financial statements analysis is a perfect complement when working with Talis Biomedical Valuation or Volatility modules.
Talis | Ebitda |
Latest Talis Biomedical's Ebitda Growth Pattern
Below is the plot of the Ebitda of Talis Biomedical Corp over the last few years. It is Talis Biomedical's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Talis Biomedical's overall financial position and show how it may be relating to other accounts over time.
Ebitda | 10 Years Trend |
|
Ebitda |
Timeline |
Talis Ebitda Regression Statistics
Arithmetic Mean | (48,294,457) | |
Coefficient Of Variation | (100.52) | |
Mean Deviation | 35,989,942 | |
Median | (20,783,000) | |
Standard Deviation | 48,543,506 | |
Sample Variance | 2356.5T | |
Range | 169.5M | |
R-Value | (0.61) | |
Mean Square Error | 1582.3T | |
R-Squared | 0.38 | |
Significance | 0.01 | |
Slope | (6,660,250) | |
Total Sum of Squares | 32990.6T |
Talis Ebitda History
About Talis Biomedical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Talis Biomedical income statement, its balance sheet, and the statement of cash flows. Talis Biomedical investors use historical funamental indicators, such as Talis Biomedical's Ebitda, to determine how well the company is positioned to perform in the future. Although Talis Biomedical investors may use each financial statement separately, they are all related. The changes in Talis Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Talis Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Talis Biomedical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Talis Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
EBITDA | -60.7 M | -63.7 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Talis Biomedical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Talis Biomedical's short interest history, or implied volatility extrapolated from Talis Biomedical options trading.
Currently Active Assets on Macroaxis
When determining whether Talis Biomedical Corp is a strong investment it is important to analyze Talis Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Talis Biomedical's future performance. For an informed investment choice regarding Talis Stock, refer to the following important reports:Check out the analysis of Talis Biomedical Correlation against competitors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Talis Stock analysis
When running Talis Biomedical's price analysis, check to measure Talis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talis Biomedical is operating at the current time. Most of Talis Biomedical's value examination focuses on studying past and present price action to predict the probability of Talis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talis Biomedical's price. Additionally, you may evaluate how the addition of Talis Biomedical to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Talis Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Talis Biomedical. If investors know Talis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Talis Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (31.43) | Revenue Per Share 0.543 | Quarterly Revenue Growth (0.94) | Return On Assets (0.34) | Return On Equity (0.69) |
The market value of Talis Biomedical Corp is measured differently than its book value, which is the value of Talis that is recorded on the company's balance sheet. Investors also form their own opinion of Talis Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Talis Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Talis Biomedical's market value can be influenced by many factors that don't directly affect Talis Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talis Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talis Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Talis Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.